Robert Ross Carter - 20 Sep 2024 Form 3 Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Financial Officer
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Robert Ross Carter
Issuer symbol
TOI
Transactions as of
20 Sep 2024
Net transactions value
$0
Form type
3
Filing time
30 Sep 2024, 16:30:08 UTC
Next filing
21 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TOI Common Stock 4,683 20 Sep 2024 Direct F1
holding TOI Common Stock 1,161 20 Sep 2024 Direct F2
holding TOI Common Stock 997 20 Sep 2024 Direct F3
holding TOI Common Stock 9,571 20 Sep 2024 Direct F4
holding TOI Common Stock 15,582 20 Sep 2024 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TOI Non-Qualified Stock Option (right to buy) 20 Sep 2024 Common Stock 11,788 $7.09 Direct F6
holding TOI Non-Qualified Stock Option (right to buy) 20 Sep 2024 Common Stock 6,747 $1.87 Direct F7
holding TOI Non-Qualified Stock Option (right to buy) 20 Sep 2024 Common Stock 31,903 $0.4810 Direct F8
holding TOI Non-Qualified Stock Option (right to buy) 20 Sep 2024 Common Stock 38,956 $2.00 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Common Stock issued upon vesting and settlement of restricted stock units ("RSUs") prior to the reporting person's appointment as an executive officer of the Company.
F2 Represents unvested RSUs awarded to the reporting person on March 21, 2022 (the "March 2022 Grant Date"). 1/4 of the RSUs vested on the first anniversary of the March 2022 Grant Date (the "March 2022 Vesting Commencement Date"), with the remaining RSUs vesting in three equal annual installments on each successive anniversary of the March 2022 Vesting Commencement Date, subject to the reporting person's continued service with the Company through the respective vesting dates.
F3 Represents unvested RSUs awarded to the reporting person on November 17, 2022 (the "November 2022 Grant Date"). 1/4 of the RSUs vested on the first anniversary of the November 2022 Grant Date (the "November 2022 RSU Vesting Commencement Date"), with the remaining RSUs vesting in three equal annual installments on each anniversary of the November 2022 Vesting Commencement Date, subject to the reporting person's continued service with the Company through the respective vesting dates.
F4 Represents unvested RSUs awarded to the reporting person on March 17, 2023 (the "2023 Grant Date"). 1/4 of the RSUs vested on the first anniversary of the 2023 Grant Date (the "2023 Vesting Commencement Date"), with the remaining RSUs vesting in three equal annual installments on each successive anniversary of the 2023 Vesting Commencement Date, subject to the reporting person's continued service with the Company through the respective vesting dates.
F5 Represents unvested RSUs awarded to the reporting person on May 21, 2024 (the "2024 Grant Date"). 1/4 of the RSUs will vest on the first anniversary of the 2024 Grant Date (the "2024 Vesting Commencement Date"), with the remaining RSUs vesting in three equal annual installments on each successive anniversary of the 2024 RSU Vesting Commencement Date, subject to the reporting person's continued service with the Company through the respective vesting dates.
F6 The stock options vest as to 1/4 of the options granted on the March 2022 Vesting Commencement Date, with the remaining options vesting in three equal annual installments on each successive anniversary of the March 2022 Vesting Commencement Date, subject to the reporting person's continued service with the Company through the respective vesting dates.
F7 The stock options vest as to 1/4 of the options granted on the November 2022 Vesting Commencement Date, with the remaining options vesting in three equal annual installments on each successive anniversary of the November 2022 Vesting Commencement Date, subject to the reporting person's continued service with the Company through the respective vesting dates.
F8 The stock options vest as to 1/4 of the options granted on the 2023 Vesting Commencement Date, with the remaining options vesting in three equal annual installments on each successive anniversary of the 2023 Vesting Commencement Date, subject to the reporting person's continued service with the Company through the respective vesting dates.
F9 The stock options vest as to 1/4 of the options granted on the 2024 Vesting Commencement Date, with the remaining options vesting in three equal annual installments on each successive anniversary of the 2024 Vesting Commencement Date, subject to the reporting person's continued service with the Company through the respective vesting dates.

Remarks:

**Exhibit List: Exhibit 24 - Power of Attorney